tumour |
schwannoma |
As nouns the difference between tumour and schwannoma
is that
tumour is (oncology|pathology) an abnormal growth; differential diagnosis includes abscess, metaplasia, and neoplasia while
schwannoma is a benign nerve sheath tumour composed of schwann cells.
tumour |
pertuzumab |
As nouns the difference between tumour and pertuzumab
is that
tumour is (oncology|pathology) an abnormal growth; differential diagnosis includes abscess, metaplasia, and neoplasia while
pertuzumab is a monoclonal antibody being developed as a drug to slow tumour growth.
tumour |
angiosarcoma |
As nouns the difference between tumour and angiosarcoma
is that
tumour is (oncology|pathology) an abnormal growth; differential diagnosis includes abscess, metaplasia, and neoplasia while
angiosarcoma is (medicine) any malignant tumour of vascular tissue.
tumour |
neuroma |
As nouns the difference between tumour and neuroma
is that
tumour is (oncology|pathology) an abnormal growth; differential diagnosis includes abscess, metaplasia, and neoplasia while
neuroma is (pathology) a tumour composed of nerve cells.
tumour |
volociximab |
As nouns the difference between tumour and volociximab
is that
tumour is (oncology|pathology) an abnormal growth; differential diagnosis includes abscess, metaplasia, and neoplasia while
volociximab is a chimeric monoclonal antibody used to treat various solid tumours.
tumour |
votumumab |
As nouns the difference between tumour and votumumab
is that
tumour is (oncology|pathology) an abnormal growth; differential diagnosis includes abscess, metaplasia, and neoplasia while
votumumab is a human monoclonal antibody used to detect colorectal tumours.
tumour |
cixutumumab |
As nouns the difference between tumour and cixutumumab
is that
tumour is (oncology|pathology) an abnormal growth; differential diagnosis includes abscess, metaplasia, and neoplasia while
cixutumumab is a monoclonal antibody used in the treatment of solid tumours.
tumour |
adecatumumab |
As nouns the difference between tumour and adecatumumab
is that
tumour is (oncology|pathology) an abnormal growth; differential diagnosis includes abscess, metaplasia, and neoplasia while
adecatumumab is a recombinant monoclonal antibody used to target tumour cells.
tumour |
oltipraz |
As nouns the difference between tumour and oltipraz
is that
tumour is (oncology|pathology) an abnormal growth; differential diagnosis includes abscess, metaplasia, and neoplasia while
oltipraz is 4-methyl-5-(2-pyrazinyl)-3-dithiolethione, a schistosomicide drug also used in tumour prevention.
tumour |
radiosensitizer |
As nouns the difference between tumour and radiosensitizer
is that
tumour is (oncology|pathology) an abnormal growth; differential diagnosis includes abscess, metaplasia, and neoplasia while
radiosensitizer is any drug that makes tumour cells more sensitive to radiation therapy.
Pages